News
A cross-sectional analysis from Yale School of Medicine estimates that approximately 5.8 million adolescents and 11.1 million ...
The study included 10,346 children with overweight or obesity but without T2D at baseline (median age, 12.5 years; 43.1% girls; 1102 with MASLD) and 59,336 matched control individuals from the ...
This analysis of T2D incidence included 2271 older participants (mean age, 68.2 years; 43.9% women) without self-reported use of diabetes medications at baseline.
Key Takeaways Semaglutide is now approved for T2D patients with CKD, reducing cardiovascular and kidney disease risks. The FLOW phase 3b trial showed significant reductions in adverse kidney and ...
The current multicenter observational cohort consisted of pregnant individuals with T2D who delivered from January 2021-April 2024. The study took place at 192 hospitals in 38 states. Data were ...
Weight management is a part of managing prediabetes, preventing T2D, and managing diabetes in general. Find out how this matters and what you can do each day.
This was evidenced in selected patients with T2D and moderate cardiovascular risk -- already on metformin and free of certain comorbidities -- in whom the risk of major adverse cardiovascular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results